BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 8106638)

  • 1. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.
    Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H
    J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
    Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein and its messenger ribonucleic acid in human adrenal tumors.
    Adleff V; Rácz K; Tóth M; Varga I; Bezzegh A; Gláz E
    J Endocrinol Invest; 1998 Dec; 21(11):753-7. PubMed ID: 9972675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
    Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.
    Reincke M; Karl M; Travis WH; Mastorakos G; Allolio B; Linehan HM; Chrousos GP
    J Clin Endocrinol Metab; 1994 Mar; 78(3):790-4. PubMed ID: 8126158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X; Fu Y; Liu S; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 alterations in uterine leiomyosarcomas versus leiomyomas.
    de Vos S; Wilczynski SP; Fleischhacker M; Koeffler P
    Gynecol Oncol; 1994 Aug; 54(2):205-8. PubMed ID: 8063247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-ras mutations in human pituitary carcinoma metastases.
    Pei L; Melmed S; Scheithauer B; Kovacs K; Prager D
    J Clin Endocrinol Metab; 1994 Apr; 78(4):842-6. PubMed ID: 8157709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
    Felix CA; Kappel CC; Mitsudomi T; Nau MM; Tsokos M; Crouch GD; Nisen PD; Winick NJ; Helman LJ
    Cancer Res; 1992 Apr; 52(8):2243-7. PubMed ID: 1559227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
    Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.